Chiome Bioscience Inc. (TYO:4583)
113.00
-3.00 (-2.59%)
At close: Feb 6, 2026
Chiome Bioscience Revenue
Chiome Bioscience had revenue of 118.02M JPY in the quarter ending September 30, 2025, a decrease of -25.73%. This brings the company's revenue in the last twelve months to 727.99M, up 25.28% year-over-year. In the year 2024, Chiome Bioscience had annual revenue of 780.81M with 14.41% growth.
Revenue (ttm)
727.99M
Revenue Growth
+25.28%
P/S Ratio
10.62
Revenue / Employee
13.74M
Employees
53
Market Cap
7.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 780.81M | 98.35M | 14.41% |
| Dec 31, 2023 | 682.46M | 51.65M | 8.19% |
| Dec 31, 2022 | 630.82M | -82.12M | -11.52% |
| Dec 31, 2021 | 712.93M | 232.08M | 48.26% |
| Dec 31, 2020 | 480.85M | 33.28M | 7.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Linical | 9.87B |
| Soiken Holdings | 4.87B |
| CellSource | 3.71B |
| StemCell Institute | 2.72B |
| MEDINET | 998.00M |
| OncoTherapy Science | 956.00M |
| PRISM BioLab Co.,LTD | 677.00M |
| ADR120S | 49.00M |